Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources

References

• Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46(197):218–223.
   PubMed Web of Science ®Google Scholar
• Hesseling P, Israels T, Harif M, Chantada G, Molyneux E. Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting. Pediatr Blood Cancer. 2013;60(3):357–362.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer. 1988;42(4):511–520.
   PubMed Web of Science ®Google Scholar
• Magrath I, Steliarova-Foucher E, Epelman S, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104–e116.
   PubMed Web of Science ®Google Scholar
• Mwanda OW, Rochford R, Rainey J, Wilson ML. Challenges in the epidemiological and clinical aspects of Burkitt’s lymphoma in Kenya: linking evidence and experience. East Afr Med J. 2004;8 Suppl:S111–S116.
   Google Scholar
• Haddow AJ. Age incidence in Burkitt’s lymphoma syndrome. East Afr Med J. 1964;41:1–6.
   Google Scholar
• Moormann AM, Snider CJ, Chelimo K. The company malaria keeps: how co-infection with Epstein–Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis. 2011;24(5):435–441.
   PubMed Web of Science ®Google Scholar
• Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1(7335):702–703.
   PubMedGoogle Scholar
• Robertson ES, editor. Burkitt’s Lymphoma. 1st ed. New York, NY: Springer; 2012.
   Google Scholar
• Burkitt D, O’Conor GT. Malignant lymphoma in African children. I. A clinical syndrome. Cancer. 1961;14:258–269.
   PubMed Web of Science ®Google Scholar
• Burkitt D. A children’s cancer with geographical limitations. Cancer Prog. 1963;92:102–113.
   Google Scholar
• Haddow AJ. An improved map for the study of Burkitt’s lymphoma syndrome in Africa. East Afr Med J. 1963;40:429–432.
   PubMedGoogle Scholar
• Dalldorf G, Linsell CA, Barnhart FE, Martyn R. An epidemiologic approach to the lymphomas of African children and Burkitt’s sarcoma of the jaws. Perspect Biol Med. 1964;7:435–449.
   Web of Science ®Google Scholar
• Burkitt D. A “tumour safari” in East and Central Africa. Br J Cancer. 1962;16:379–386.
   PubMed Web of Science ®Google Scholar
• Dalldorf G, Barnhart FE. Childhood leukemia, malaria and Burkitt’s lymphoma. N Engl J Med. 1972;286(22):1216.
   Web of Science ®Google Scholar
• Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R. Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk. Trop Med Int Health. 2007;12(8):936–943.
   PubMed Web of Science ®Google Scholar
• Rainey JJ, Omenah D, Sumba PO, Moormann AM, Rochford R, Wilson ML. Spatial clustering of endemic Burkitt’s lymphoma in high-risk regions of Kenya. Int J Cancer. 2007;120(1):121–127.
   Web of Science ®Google Scholar
• Moss DJ, Burrows SR, Castelino DJ, et al. A comparison of Epstein–Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int J Cancer. 1983;31(6):727–732.
   Web of Science ®Google Scholar
• Whittle HC, Brown J, Marsh K, et al. T-cell control of Epstein–Barr virus-infected B-cells is lost during P. falciparum malaria. Nature. 1984;312(5993):449–450.
   Web of Science ®Google Scholar
• Donati D, Mok B, Chene A, et al. Increased B-cell survival and preferential activation of the memory compartment by a malaria polyclonal B-cell activator. J Immunol. 2006;177(5):3035–3044.
   Web of Science ®Google Scholar
• Piriou E, Asito AS, Sumba PO, et al. Early age at time of primary Epstein–Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis. 2012;205(6):906–913.
   Web of Science ®Google Scholar
• Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria? Parasitol Today. 1991;7(10):277–281.
   Google Scholar
• Sumba PO, Kabiru EW, Namuyenga E, et al. Microgeographic variations in Burkitt’s lymphoma incidence correlate with differences in malnutrition, malaria, and Epstein–Barr virus. Br J Cancer. 2010;103(11):1736–1741.
   Web of Science ®Google Scholar
• van den Bosch CA. Is endemic Burkitt’s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol. 2004;5(12):738–746.
   Web of Science ®Google Scholar
• Orem J, Maganda A, Mbidde EK, Weiderpass E. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Pediatr Blood Cancer. 2009;52(4):455–458.
   PubMed Web of Science ®Google Scholar
• Schulz TF, Boshoff CH, Weiss RA. HIV infection and neoplasia. Lancet. 1996;348(9027):587–591.
   Web of Science ®Google Scholar
• Davidson A, Wainwright RD, Stones DK, et al. Malignancies in South African children with HIV. J Pediatr Hematol Oncol. 2014;36(2):111–117.
   PubMed Web of Science ®Google Scholar
• Stefan DC, Stones DK. Children with cancer and HIV infection: what is different about them? J Pediatr Hematol Oncol. 2013;35(8):590–596.
   PubMed Web of Science ®Google Scholar
• Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein–Barr virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208(8):1286–1293.
   PubMed Web of Science ®Google Scholar
• Condon LM, Cederberg LE, Rabinovitch MD, et al. Age-specific prevalence of Epstein–Barr virus infection among Minnesota children effects of race/ethnicity and family environment. Clin Infect Dis. Epub May 11, 2014.
   Google Scholar
• Balfour HH Jr. Progress, prospects, and problems in Epstein–Barr virus vaccine development. Curr Opin Virol. 2014;6C:1–5.
   Web of Science ®Google Scholar
• Lindblade KA, Eisele TP, Gimnig JE, et al. Sustainability of reductions in malaria transmission and infant mortality in Western Kenya with use of insecticide-treated bednets: 4 to 6 years of follow-up. JAMA. 2004;291(21):2571–2580.
   Web of Science ®Google Scholar
• Mathenge EM, Gimnig JE, Kolczak M, Ombok M, Irungu LW, Hawley WA. Effect of permethrin-impregnated nets on exiting behavior, blood feeding success, and time of feeding of malaria mosquitoes (Diptera: Culicidae) in Western Kenya. J Med Entomol. 2001;38(4):531–536.
   Web of Science ®Google Scholar
• Strode C, Donegan S, Garner P, Enayati AA, Hemingway J. The impact of pyrethroid resistance on the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review and meta-analysis. PLoS Med. 2014;11(3):e1001619.
   Web of Science ®Google Scholar
• Patel JD, Galsky MD, Chagpar AB, Pyle D, Loehrer PJ. Role of American Society of Clinical Oncology in low- and middle-income countries. J Clin Oncol. 2011;29(22):3097–3102.
   Web of Science ®Google Scholar
• Buckle GC, Collins JP, Sumba PO, et al. Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt lymphoma among children in Uganda and Western Kenya: a cross-sectional survey. Infect Agent Cancer. 2013;8(1):36.
   Google Scholar
• Razack R, Michelow P, Leiman G, et al. An interinstitutional review of the value of FNAB in pediatric oncology in resource-limited countries. Diagn Cytopathol. 2012;40(9):770–776.
   Web of Science ®Google Scholar
• Parham GP, Mwanahamuntu MH, Pfaendler KS, et al. eC3 – a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis. 2010;14(3):167–173.
   PubMed Web of Science ®Google Scholar
• Korir A, Mauti N, Moats P, et al. Developing clinical strength-of-evidence approach to define HIV-associated malignancies for cancer registration in Kenya. PLoS One. 2014;9(1):e85881.
   Web of Science ®Google Scholar
• Magrath I, Lee YJ, Anderson T, et al. Prognostic factors in Burkitt’s lymphoma: importance of total tumor burden. Cancer. 1980;45(6):1507–1515.
   PubMed Web of Science ®Google Scholar
• Garba IH, Ubom GA. Total serum lactate dehydrogenase activity in acute Plasmodium falciparum malaria infection. Singapore Med J. 2005;46(11):632–634.
   Google Scholar
• Simon R. Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology. Per Med. 2010;7(1):33–47.
   PubMed Web of Science ®Google Scholar
• Oettgen HF, Burkitt D, Burchenal JH. Malignant lymphoma involving the jaw in African children: treatment with methotrexate. Cancer. 1963;16:616–623.
   Web of Science ®Google Scholar
• Burkitt D, Hutt MS, Wright D. The African lymphoma: preliminary observations on response to therapy. Cancer. 1965;18:399–410.
   PubMed Web of Science ®Google Scholar
• Burkitt D. African lymphoma. Observations on response to vincristine sulphate therapy. Cancer. 1966;19(8):1131–1137.
   Web of Science ®Google Scholar
• Morrow RH, Pike MC, Kisuule A. Survival of Burkitt’s lymphoma patients in Mulago Hospital, Uganda. Br Med J. 1967;4(5575):323–327.
   Google Scholar
• Williams EH. Chemotherapy of Burkitt’s lymphoma. Br Med J. 1969;2(5659):764.
   Google Scholar
• Williams EH. A comparison of results achieved in treating two series of patients with Burkitt’s lymphoma. Br J Cancer. 1971;25(1):37–45.
   Web of Science ®Google Scholar
• Ziegler JL. Chemotherapy of Burkitt’s lymphoma. Cancer. 1972;30(6):1534–1540.
   Web of Science ®Google Scholar
• Nkrumah FK, Perkins IV. Burkitt’s lymphoma in Ghana: clinical features and response to chemotherapy. Int J Cancer. 1973;11(1):19–29.
   Web of Science ®Google Scholar
• Nkrumah FK, Perkins IV. Burkitt’s lymphoma: a clinical study of 110 patients. Cancer. 1976;37(2):671–676.
   Web of Science ®Google Scholar
• Nkrumah FK, Perkins IV, Biggar RJ. Combination chemotherapy in abdominal Burkitt’s lymphoma. Cancer. 1977;40(4):1410–1416.
   Web of Science ®Google Scholar
• Anderson JR, Wilson JF, Jenkin DT, et al. Childhood non-Hodgkin’s lymphoma. The results of a randomized therapeutic trial comparing a four-drug regimen (COMP) with a ten-drug regimen (LSA2-L2). N Engl J Med. 1983;308(10):559–565.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Michon J, et al. The Societe Francaise d’Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97(11):3370–3379.
   PubMed Web of Science ®Google Scholar
• Hesseling PB, Broadhead R, Molyneux E, et al. Malawi pilot study of Burkitt lymphoma treatment. Med Pediatr Oncol. 2003;41(6):532–540.
   Google Scholar
• Sandlund JT, Downing JR, Crist WM. Non-Hodgkin’s lymphoma in childhood. N Engl J Med. 1996;334(19):1238–1248.
   PubMed Web of Science ®Google Scholar
• Njuguna F, Mostert S, Slot A, et al. Abandonment of childhood cancer treatment in Western Kenya. Arch Dis Child. Epub March 28, 2014.
   Google Scholar
• Mostert S, Njuguna F, van de Ven PM, et al. Influence of health-insurance access and hospital retention policies on childhood cancer treatment in Kenya. Pediatr Blood Cancer. 2014;61(5):913–918.
   Web of Science ®Google Scholar
• Lu TX, Mai WY, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58(3):682–687.
   Web of Science ®Google Scholar
• Donaldson SS, Wesley MN, DeWys WD, Suskind RM, Jaffe N, van Eys J. A study of the nutritional status of pediatric cancer patients. Am J Dis Child. 1981;135(12):1107–1112.
   PubMedGoogle Scholar
• Lobato-Mendizabal E, Ruiz-Arguelles GJ, Marin-Lopez A. Leukaemia and nutrition. I: malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res. 1989;13(10):899–906.
   PubMed Web of Science ®Google Scholar
• Mejia-Arangure JM, Fajardo-Gutierrez A, Reyes-Ruiz NI, et al. Malnutrition in childhood lymphoblastic leukemia: a predictor of early mortality during the induction-to-remission phase of the treatment. Arch Med Res. 1999;30(2):150–153.
   PubMed Web of Science ®Google Scholar
• Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child. 1994;71(4):304–310.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487(7407):330–337.
   PubMed Web of Science ®Google Scholar
• Kazembe P, Hesseling PB, Griffin BE, Lampert I, Wessels G. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediatr Oncol. 2003;40:23–25.
   PubMedGoogle Scholar
• Traore F, Coze C, Atteby JJ, et al. Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer. 2011;56:70–76.
   PubMed Web of Science ®Google Scholar
• Hesseling P, Molyneux E, Kamiza S, Israels T, Broadhead R. Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr. 2009;29:29–34.
   PubMed Web of Science ®Google Scholar
• Koffi GK, Tolo A, Nanho DC, et al. Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Cote d’Ivoire. International journal of hematology. 2010;91:838–843.
   Web of Science ®Google Scholar
• Ngoma T, Adde M, Durosinmi M, et al. Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease. Br J Haematol. 2012;158:749–762.
   Web of Science ®Google Scholar
• Hesseling P, Broadhead R, Mansvelt E, et al. The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer. 2005;44:245–250.
   PubMed Web of Science ®Google Scholar
• Davidson A, Desai F, Hendricks M, et al. The evolving management of Burkitt’s lymphoma at Red Cross Children’s Hospital. S Afr Med J. 2006;96:950–954.
   Web of Science ®Google Scholar
• Hesseling P, McCormick P, Kouya F, et al. Burkitt lymphoma: residual abdominal tumor volume after induction therapy correlates with outcome. Pediatr Blood Cancer. 2010;55:761–762.
   PubMed Web of Science ®Google Scholar
• Harif M, Barsaoui S, Benchekroun S, et al. Treatment of B-cell lymphoma with LMB modified protocols in Africa—report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer. 2008;50:1138–1142.
   PubMed Web of Science ®Google Scholar